← Open Payments lookup

AVNEET KAUR: Open Payments

NPI 1144704735 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$651 in 13 payments from 8 companies in 2025. Trend: 2023 $640 · 2024 $644 · 2025 $651

Food & beverage: $651
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.1$139
Janssen Pharmaceuticals, Inc1$104
Otsuka Pharmaceutical Development & Commercialization, Inc.1$97
Alexion Pharmaceuticals, Inc.1$94
Novo Nordisk Inc4$83
Lilly USA, LLC3$82
Astellas Pharma US Inc1$34
Esperion Therapeutics, Inc.1$18

Products named: INGREZZA, SPRAVATO, Wegovy, MOUNJARO, Veozah, ZEPBOUND, NEXLETOL.

Industry payments across MD — which companies pay providers there.